Vidaza Injection, Powder, Lyophilized, For Solution
Product Images NDC 59572-102

4 FDA label images from Celgene Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vidaza (NDC 59572-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azacitidinestructuralformula (Azacitidinestructuralformula)

Azacitidinestructuralformula (Azacitidinestructuralformula)
Chemical structure of azacitidine, the active ingredient in VIDAZA. The diagram shows the molecular arrangement with nitrogen, oxygen, and carbon atoms forming the characteristic structure of this nucleoside analog drug used in injection form.*
FDA Label Image

Kaplan-meier Curve Of Time To Death From Any Cause: (intent-to-treat Population) (Image 01)

Kaplan-meier Curve Of Time To Death From Any Cause:  (intent-to-treat Population) (Image 01)
A Kaplan-Meier survival curve chart comparing the proportion of patients surviving over time (in months) from randomization for VIDAZA (azacitidine) versus CCR. The chart includes survival curves labeled AZA and CCR, a table of numbers at risk beneath the time axis, and statistical values such as log-rank p-value, hazard ratio with confidence interval, and death counts for each group.*
FDA Label Image

Vidaza-label (Vidaza Label.png)

Vidaza-label (Vidaza Label.png)
Label for VIDAZA azacitidine for injection, 100 mg single-dose vial for subcutaneous and intravenous use. The sterile lyophilized powder is for injection and is manufactured by Bristol-Myers Squibb Company. The label includes storage instructions and cautions, and shows the NDC number 59572-102-01.*
FDA Label Image

Vidaza-carton (Vidaza Carton.png)

Vidaza-carton (Vidaza Carton.png)
VIDAZA 100 mg single-dose vial lyophilized powder for injection label. The label indicates azacitidine for injection, for subcutaneous and intravenous use only, marketed by Bristol-Myers Squibb Company. The packaging includes usage instructions and regulatory markings, with a barcode and product NDC 59572-102-01. The product is a lyophilized powder vial intended for injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.